Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › FDA Authorizes Use of Pooled Samples With CDC Coronavirus Test

FDA Authorizes Use of Pooled Samples With CDC Coronavirus Test

Dec 04, 2020
|
staff reporter

NEW YORK — The US Food and Drug Administration on Tuesday reissued an Emergency Use Authorization for the US Centers for Disease Control and Prevention's PCR-based SARS-CoV-2 test to allow its use with pooled samples.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Molecular Diagnostics

  1. Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

  2. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

  3. CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon

  4. Jonathan Rothberg-Led Startup Looks to Bring Disposable POC SARS-CoV-2 Test to Market

    Premium

  5. Invitae to Raise $400M in Proposed Public Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.